搜索
Tevogen Bio Holdings Inc
TVGN添加自选
6.690USD
-0.030-0.45%
收盘 07-31 16:00（美东）报价延迟15分钟
537.98K总市值
亏损市盈率 TTM
关于 Tevogen Bio Holdings Inc 公司
Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The Company is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, has developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic lingering symptoms of the disease. Its TVGN 601 is being developed for multiple sclerosis (MS), and its TVGN 930 is being developed for EBV-associated lymphomas.
Tevogen Bio Holdings Inc简介
公司代码TVGN
公司名称Tevogen Bio Holdings Inc
上市日期Nov 04, 2021
CEOSaadi (Ryan)
员工数量18
证券类型Ordinary Share
年结日Nov 04
公司地址15 Independence Boulevard, Suite #210
城市WARREN
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编07059
电话16468078832
网址https://tevogen.com/
公司代码TVGN
上市日期Nov 04, 2021
CEOSaadi (Ryan)
Tevogen Bio Holdings Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Kirti Desai
Mr. Kirti Desai
Chief Financial Officer
Chief Financial Officer
242.98K
+16.46%
Dr. Neal Flomenberg, M.D.
Dr. Neal Flomenberg, M.D.
Chief Scientific Officer and Global R&D Lead
Chief Scientific Officer and Global R&D Lead
74.52K
+3.25%
Mr. Jeffrey Feike
Mr. Jeffrey Feike
Independent Director
Independent Director
54.03K
+74.03%
Dr. Keow Lin (Lindee) Goh
Dr. Keow Lin (Lindee) Goh
Independent Director
Independent Director
46.28K
+86.43%
Ms. Susan M. Podlogar
Ms. Susan M. Podlogar
Independent Director
Independent Director
46.28K
+86.43%
Mr. Sadiq Khan
Mr. Sadiq Khan
Chief Commercial Officer
Chief Commercial Officer
4.00K
--
Dr. Ryan Saadi, M.D.
Dr. Ryan Saadi, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Curtis Patton
Dr. Curtis Patton
Independent Director
Independent Director
--
--
Mr. Victor Sordillo
Mr. Victor Sordillo
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Kirti Desai
Mr. Kirti Desai
Chief Financial Officer
Chief Financial Officer
242.98K
+16.46%
Dr. Neal Flomenberg, M.D.
Dr. Neal Flomenberg, M.D.
Chief Scientific Officer and Global R&D Lead
Chief Scientific Officer and Global R&D Lead
74.52K
+3.25%
Mr. Jeffrey Feike
Mr. Jeffrey Feike
Independent Director
Independent Director
54.03K
+74.03%
Dr. Keow Lin (Lindee) Goh
Dr. Keow Lin (Lindee) Goh
Independent Director
Independent Director
46.28K
+86.43%
Ms. Susan M. Podlogar
Ms. Susan M. Podlogar
Independent Director
Independent Director
46.28K
+86.43%
Mr. Sadiq Khan
Mr. Sadiq Khan
Chief Commercial Officer
Chief Commercial Officer
4.00K
--
常见问题
Tevogen Bio Holdings Inc的前五大股东是谁？
Tevogen Bio Holdings Inc 的前五大股东如下：Mr. Kirti Desai
有多少机构持有Tevogen Bio Holdings Inc(TVGN)的股份？
截至2026Q1，共有115家机构持有Tevogen Bio Holdings Inc的股份，合计持有的股份价值约为168.15K，占公司总股份的4.02%。与2025Q4相比，机构持股有所增加，增幅为-44192.00。